These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6848791)
1. Blood substitutes: two ways to get there. Cowart VS JAMA; 1983 Jan; 249(2):159, 163-4. PubMed ID: 6848791 [No Abstract] [Full Text] [Related]
2. Choice of blood substitutes in Chicago. Cowart VS JAMA; 1983 Jan; 249(2):164, 166. PubMed ID: 6848792 [No Abstract] [Full Text] [Related]
3. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
8. Blood component therapy in anaesthetic practice. Blajchman MA; Herst R; Perrault RA Can Anaesth Soc J; 1983 Jul; 30(4):382-9. PubMed ID: 6347352 [No Abstract] [Full Text] [Related]
9. Blood and plasma substitutes--plasma expansion and oxygen transport properties. Waxman K; Tremper KK; Mason GR West J Med; 1985 Aug; 143(2):202-6. PubMed ID: 2412350 [TBL] [Abstract][Full Text] [Related]
10. FDA committee questions Fluosol efficacy; US approval not imminent. Marwick C JAMA; 1983 Nov; 250(19):2585-6. PubMed ID: 6632147 [No Abstract] [Full Text] [Related]
11. Can "artificial blood' live up to public billing? Cowart VS JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595 [No Abstract] [Full Text] [Related]
12. Tissue oxygenation by fluorocarbons. Faithfull NS; Fennema M; Erdmann W; Lapin R; Smith AR; Van Alphen W; Essed CE; Trouwborst A Adv Exp Med Biol; 1984; 180():569-80. PubMed ID: 6534130 [No Abstract] [Full Text] [Related]
13. [Chemical modification of hemoglobin and blood substitutes]. Bai JS; Bu FR Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):71-3. PubMed ID: 12545784 [No Abstract] [Full Text] [Related]
14. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation. Yang FS; Caldwell KD; Giddings JC; Astle L Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424 [TBL] [Abstract][Full Text] [Related]
15. A blood substitute from hydroxyethyl starch and hemoglobin. Cerny LC; Cerny EL; Robach J; Reath M; Pontero L Appl Biochem Biotechnol; 1984; 10():151-3. PubMed ID: 6084473 [TBL] [Abstract][Full Text] [Related]
16. Perfluorochemical emulsion oxygen transport fluids: a clinical review. Tremper KK; Anderson ST Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055 [TBL] [Abstract][Full Text] [Related]
17. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study. Kagawa S; Koshu K; Yoshimoto T; Suzuki J Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373 [No Abstract] [Full Text] [Related]
19. Current perspectives on blood substitutes. Gould SA; Moss G Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573 [No Abstract] [Full Text] [Related]
20. The influence of a temporary cessation and reperfusion of intestinal blood flow on the level of hepatic lipid peroxides. Lutz J; Augustin A Adv Exp Med Biol; 1989; 248():803-8. PubMed ID: 2476917 [No Abstract] [Full Text] [Related] [Next] [New Search]